Shares of Laser Photonics (LASE) cratered 24.6% to $0.88 on Thursday after the company priced a $5 million public equity offering at $0.70 per share — a roughly 40% discount to the prior close of $1.16. The deal, which includes warrants giving buyers the right to purchase even more shares later, marks the latest in a string of cash raises that are rapidly inflating the share count and eroding existing investors' stakes.
• The Share Count Has Nearly Doubled in Six Months, and It's Not Done. Laser Photonics issued 7.1 million new shares in a February offering that ballooned the count from 22.8 million at year-end 2025 to 32.6 million by March 31, 2026.
By mid-May, shares outstanding had reached 38.6 million.
Morningstar data pegged the figure at 47.65 million as of early July. Today's offering adds millions more — and the accompanying warrants create a further overhang of potential future dilution, a pattern that has averaged roughly a 21% one-day price decline each time the company taps this playbook.
• Revenue Is Collapsing While Losses Mount. Q1 2026 net sales plunged 60% year-over-year to just $915,553, producing a gross loss of $388,451 — meaning the company lost money on every dollar of product it sold.
Cash stood at only $1.6 million with a $4 million working capital deficit, and auditors flagged "substantial doubt" about the company's ability to continue as a going concern. That context explains why management keeps returning to dilutive offerings: it has no other reliable funding source.
• Defense Headlines Haven't Translated to Real Revenue. The company has touted its anti-drone system's selection by the U.S. Department of War, entry into medical devices, and a $13.2 million Navy order. But quarterly sales under $1 million show these milestones remain largely aspirational. Analysts note that the going concern warning and history of heavy losses "keep financing and dilution risk front and center, even as third party validation improves."
• The Offering Price Itself Sends a Signal. Pricing at $0.70 — well below even today's beaten-down market price — tells investors that institutional buyers demanded a steep discount to absorb the risk. One community fair-value estimate pegs the stock at just $0.60. With each successive raise priced lower than the last, the company is effectively signaling that survival capital takes priority over protecting shareholder value — a dynamic that typically doesn't reverse until the business can fund itself from actual product sales.